Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Clinical trial NCT03842696 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03842696
Sponsor: University of Michigan Rogel Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Diseases Acute Leukemia in Remission Chronic Myelogenous Leukemia - Chronic Phase Chronic Myelogenous Leukemia, Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Myelodysplastic Syndromes Mantle Cell Lymphoma Follicular Lymphoma Diffuse Large B Cell Lymphoma Non Hodgkin Lymphoma Graft Vs Host Disease Graft-versus-host-disease

Start date: 2020-02-04
Primary completion: 2025-07-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.